Authors:
FIELDS KK
ZORSKY PE
HIEMENZ JW
KRONISH LE
ELFENBEIN GJ
Citation: Kk. Fields et al., IFOSFAMIDE, CARBOPLATIN, AND ETOPOSIDE - A NEW REGIMEN WITH A BROAD-SPECTRUM OF ACTIVITY, Journal of clinical oncology, 12(3), 1994, pp. 544-552
Citation: Jw. Lynch et al., PURE RED-CELL APLASIA ASSOCIATED WITH ANGIOIMMUNOBLASTIC LYMPHADENOPATHY WITH DYSPROTEINEMIA, American journal of hematology, 46(2), 1994, pp. 72-78
Authors:
JANSSEN WE
HIEMENZ JW
FIELDS KK
ZORSKY PE
BALLESTER OF
GOLDSTEIN SC
SMILEE R
KRONISH L
ELFENBEIN GJ
Citation: We. Janssen et al., PERIPHERAL-BLOOD STEM-CELLS DO NOT ALWAYS PRODUCE FASTER ENGRAFTMENT THAN BONE-MARROW IN AUTOTRANSPLANTATION, Experimental hematology, 22(8), 1994, pp. 765-765
Authors:
FIELDS KK
ELFENBEIN GJ
PERKINS JP
BALLESTER OF
HIEMENZ JW
ZORSKY PE
Citation: Kk. Fields et al., EVENT-FREE SURVIVAL IN BREAST-CANCER PATIENTS TREATED WITH HIGH-DOSE IFOSFAMIDE, CARBOPLATIN, AND ETOPOSIDE AND AUTOLOGOUS STEM-CELL RESCUE- ANALYSIS OF RISK-FACTORS, Experimental hematology, 22(8), 1994, pp. 779-779
Authors:
ELFENBEIN GJ
FIELDS KK
PERKINS JB
BALLESTER OF
GOLDSTEIN SC
HIEMENZ JW
ZORSKY PE
Citation: Gj. Elfenbein et al., TIME TO RELAPSE AFTER HIGH-DOSE CHEMOTHERAPY WITH 2 NOVEL REGIMENS FOR METASTATIC BREAST-CANCER, Experimental hematology, 22(8), 1994, pp. 780-780
Authors:
BALLESTER OF
AGALIOTIS DP
JANSSEN WE
FIELDS KK
HIEMENZ JW
ZORSKY PE
GOLDSTEIN SC
ELFENBEIN GJ
Citation: Of. Ballester et al., PATTERNS OF PLATELET RECOVERY AFTER BUSULFAN CYCLOPHOSPHAMIDE AND PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION IN PATIENTS WITH HEMATOLOGICALMALIGNANCIES/, Experimental hematology, 22(8), 1994, pp. 782-782
Authors:
PERKINS JB
CREMERS KA
FIELDS KK
JANSSEN WE
BALLESTER OF
GOLDSTEIN SC
HIEMENZ JW
ZORSKY PE
ELFENBEIN GJ
Citation: Jb. Perkins et al., DIFFERENCES IN ENGRAFTMENT RATE BETWEEN 2 GROUPS OF BREAST-CANCER PATIENTS TREATED WITH THE SAME HIGH-DOSE CHEMOTHERAPY REGIMEN - POTENTIALCONTRIBUTING FACTORS FOR HEMATOPOIETIC RECOVERY, Experimental hematology, 22(8), 1994, pp. 782-782
Authors:
FIELDS KK
ELFENBEIN GJ
PERKINS JB
JANSSEN WE
BALLESTER OF
HIEMENZ JW
ZORSKY PE
KRONISH LE
FOODY MC
Citation: Kk. Fields et al., HIGH-DOSE IFOSFAMIDE CARBOPLATIN/ETOPOSIDE - MAXIMUM TOLERABLE DOSES,TOXICITIES, AND HEMATOPOIETIC RECOVERY AFTER AUTOLOGOUS STEM-CELL REINFUSION/, Seminars in oncology, 21(5), 1994, pp. 86-92
Authors:
BALDUCCI L
BENSON K
LYMAN GH
SANDERSON R
FIELDS K
BALLESTER OF
ELFENBEIN GJ
Citation: L. Balducci et al., COST-EFFECTIVENESS OF WHITE CELL-REDUCTION FILTERS IN TREATMENT OF ADULT ACUTE MYELOGENOUS LEUKEMIA - REPLY, Transfusion, 34(4), 1994, pp. 359-359
Authors:
JANSSEN WE
PERKINS J
HIEMENZ JW
FIELDS KK
ZORSKY PE
BALLESTER OF
GOLDSTEIN SC
SMILEE R
KRONISH L
ELFENBEIN GJ
Citation: We. Janssen et al., GRANULOCTE RECOVERY IS NOT DIFFERENT FOLLOWING AUTOTRANSPLANT WITH G-CSF PRIMED BONE-MARROW OR G-CSF MOBILIZED PERIPHERAL-BLOOD STEM-CELLS, Blood, 84(10), 1994, pp. 10000095-10000095
Authors:
BALLESTER OF
MOSCINSKI LC
FIELDS KK
HIEMENZ JW
ZORSKY PE
GOLDSTEIN SC
SABA HI
SPIERS ASD
KRONISH LE
ELFENBEIN GJ
Citation: Of. Ballester et al., PHASE I-II TRIAL OF DC-IE - A NOVEL, INTENSIVE INDUCTION CHEMOTHERAPYREGIMEN FOR MULTIPLE-MYELOMA (MM), Blood, 84(10), 1994, pp. 10000179-10000179
Authors:
PERKINS JB
FIELDS KK
ELFENBEIN GJ
BALLESTER OF
GOLDSTEIN SC
HIEMENZ JW
ZORSKY PE
Citation: Jb. Perkins et al., USE OF GM-CSF (LEUKINE(R) SARGRAMOSTIM) AS A CHEMOPROTECTANT PRIOR TOIFOSFAMIDE, CARBOPLATIN, AND ETOPOSIDE - PRELIMINARY-RESULTS OF A RANDOMIZED, CONTROLLED TRIAL, Blood, 84(10), 1994, pp. 10000585-10000585
Authors:
ELFENBEIN GJ
PERKINS JB
FIELDS KK
BALLESTER OF
GOLDSTEIN SC
HIEMENZ JW
JANSSEN WE
ZORSKY RE
Citation: Gj. Elfenbein et al., HEMATOLOGIC RECOVERY AFTER HIGH-DOSE TAXOL(R) NOVANTRONE(R), THIOTEPA(TNT) AND AUTOLOGOUS STEM-CELL TRANSPLANT - EVALUATION OF THE EFFECTSOF STEM-CELL SOURCE AND TAXOL, Blood, 84(10), 1994, pp. 10000707-10000707
Authors:
AGALIOTIS DP
FIELDS KK
BALLESTER OF
HIEMENZ JW
ZORSKY PE
JANSSEN WE
PERKINS JB
PACH LD
ELFENBEIN GJ
Citation: Dp. Agaliotis et al., EVENT-FREE SURVIVAL IN PATIENTS WITH METASTATIC BREAST-CANCER UNDERGOING HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW OR PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION, Experimental hematology, 21(8), 1993, pp. 1130-1130
Authors:
JANSSEN WE
HIEMENZ J
ZORSKY PE
FIELDS KK
BALLESTER O
PERKINS J
KRONISH L
SMILEE R
CARTER R
RAHN D
ELFENBEIN GJ
Citation: We. Janssen et al., MOBILIZATION OF PERIPHERAL-BLOOD STEM-CELLS - COMPARING CELL COLLECTIONS FROM CYCLOPHOSPHAMIDE AND GROWTH-FACTOR BASED REGIMENS, Experimental hematology, 21(8), 1993, pp. 1164-1164
Authors:
ELFENBEIN GJ
JANSSEN WE
HIEMENZ JW
FIELDS KK
ZORSKY PE
BALLESTER OF
PERKINS JB
Citation: Gj. Elfenbein et al., FACTORS AFFECTING THE RATE OF ENGRAFTMENT FOLLOWING AUTOLOGOUS STEM-CELL RESCUE - CONDITIONING REGIMEN, Experimental hematology, 21(8), 1993, pp. 1164-1164
Authors:
HIEMENZ JW
JANSSEN WE
FIELDS KK
ZORSKY PE
BALLESTER OF
PERKINS JB
ELFENBEIN GJ
Citation: Jw. Hiemenz et al., FACTORS AFFECTING THE RATE OF ENGRAFTMENT FOLLOWING AUTOLOGOUS STEM-CELL REINFUSION - METHODS OF PERIPHERAL-BLOOD STEM-CELL MOBILIZATION, Experimental hematology, 21(8), 1993, pp. 1164-1164
Citation: Gj. Elfenbein, BONE-MARROW TRANSPLANTATION IN THE 1990S - CONTROVERSIES AND CONSENSUS - INTRODUCTION, Seminars in oncology, 20(5), 1993, pp. 1-1
Authors:
FIELDS KK
ELFENBEIN GJ
PERKINS JB
HIEMENZ JW
JANSSEN WE
ZORSKY PE
BALLESTER OF
KRONISH LE
FOODY MC
Citation: Kk. Fields et al., 2 NOVEL HIGH-DOSE TREATMENT REGIMENS FOR METASTATIC BREAST-CANCER - IFOSFAMIDE, CARBOPLATIN, PLUS ETOPOSIDE AND MITOXANTRONE PLUS THIOTEPA - OUTCOMES AND TOXICITIES, Seminars in oncology, 20(5), 1993, pp. 59-66
Authors:
BALDUCCI L
BENSON K
LYMAN GH
SANDERSON R
FIELDS K
BALLESTER OF
ELFENBEIN GJ
Citation: L. Balducci et al., COST-EFFECTIVENESS OF WHITE CELL-REDUCTION FILTERS IN TREATMENT OF ADULT ACUTE MYELOGENOUS LEUKEMIA, Transfusion, 33(8), 1993, pp. 665-670
Authors:
JANSSEN WE
MUELLER G
FARMELO MJ
ELFENBEIN GJ
Citation: We. Janssen et al., COMPARISON OF RESPONSIVENESS OF BONE-MARROW OR BLOOD-BORNE HEMATOPOIETIC PROGENITORS TO GROWTH-FACTORS IN-VITRO, Blood, 82(10), 1993, pp. 10000485-10000485